Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Endocr Pathol. 2018 Dec;29(4):357-364. doi: 10.1007/s12022-018-9548-1.
Although differentiated thyroid carcinomas typically pursue an indolent clinical course, it is important to identify the subset of tumors that are most likely to behave aggressively so that patients with these tumors are counseled and treated appropriately. Extent of disease is fundamental to the prognostication for differentiated thyroid carcinoma; however, there are additional histologic features of the tumor separate from extent of disease that have been shown to affect clinical course. This review will start with a discussion of aggressive variants of papillary thyroid carcinoma, move to the prognostic significance of vascular invasion in follicular thyroid carcinoma, and finish with a discussion of Hürthle cell carcinoma, with an emphasis on why it is not considered a subtype of follicular thyroid carcinoma in the 2017 WHO Classification of Tumors of Endocrine Organs.
尽管分化型甲状腺癌通常表现为惰性的临床病程,但识别最有可能具有侵袭性行为的肿瘤亚组非常重要,以便对这些肿瘤的患者进行适当的咨询和治疗。疾病的范围是预测分化型甲状腺癌的基础;然而,肿瘤的其他组织学特征与疾病的范围分开,已被证明会影响临床病程。这篇综述将首先讨论甲状腺乳头状癌的侵袭性变异型,然后讨论滤泡状甲状腺癌中血管侵犯的预后意义,最后讨论 Hurthle 细胞癌,并强调为什么它在 2017 年世界卫生组织内分泌器官肿瘤分类中不被认为是滤泡状甲状腺癌的一个亚型。